Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

8-cyclopentlyl-1,3-dipropylxanthine

EU orphan designation number: EU/3/01/030
Active ingredient: 8-cyclopentlyl-1,3-dipropylxanthine
Indication: Treatment of cystic fibrosis
Sponsor: SciClone Pharmaceuticals Italy S.r.l
Via Lisbona 11, I-00198 Roma, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/03/2001 Orphan Designation EMEA/OD/064/00 (2001)949 of 29/03/2001
04/08/2008 Removal of orphan designation from Community Register